Table 2.
ADMET profile of diverse anti-viral drugs and their metabolism fragments.
| Drugs | MS fragments | MW | logP | D.H/A.H | logS | Intestinal absortion (%) | CNS | Tox (LD50) |
|---|---|---|---|---|---|---|---|---|
| Favipiravir | 157.104 | − 0.992 | 2/3 | − 2.103 | 81.635 | − 3.111 | 1.929 | |
| 44 m/z | 47.057 | − 1.105 | 2/2 | 1.465 | 84.154 | − 2.696 | 1.878 | |
| 113 m/z | 114.079 | − 0.091 | 1/2 | − 0.781 | 94.787 | − 2.932 | 2.131 | |
| 43 m/z | 43.025 | − 0.099 | 2/1 | 0.747 | 94.232 | − 2.638 | 2.200 | |
| 114 m/z | 116.095 | − 0.517 | 1/2 | − 0.001 | 100 | − 2.996 | 2.208 | |
| Galidesivir | 267.289 | − 1.847 | 7/7 | − 2.467 | 45.167 | − 4.859 | 2.548 | |
| 59 m/z | 59.068 | − 0.372 | 2/2 | 0.967 | 85.397 | − 2.910 | 1.996 | |
| 206 m/z | 208.221 | − 0.755 | 5/5 | − 2.394 | 65.857 | − 3.948 | 2.338 | |
| 31 m/z | 32.042 | − 0.392 | 1/1 | 1.075 | 98.165 | − 2.566 | 2.029 | |
| 234 m/z | 237.263 | − 1.208 | 6/6 | − 2.626 | 58.026 | − 4.036 | 2.509 | |
| 27 m/z | 27.026 | 0.140 | 1/0 | 0.162 | 100 | − 2.375 | 2.351 | |
| 74 m/z | 76.095 | − 0.639 | 2/2 | 0.973 | 84.782 | − 2.841 | 1.522 | |
| 163 m/z | 170.216 | − 2.148 | 4/5 | − 1.142 | 65.04 | − 3.959 | 2.081 | |
| Nitazoxanide | 307.287 | 2.229 | 1/7 | − 3.826 | 79.029 | − 2.979 | 2.472 | |
| 43 m/z I | 46.069 | − 0.001 | 1/1 | 0.782 | 98.262 | − 2.611 | 2.028 | |
| 120 m/z | 122.123 | 0.663 | 0/2 | − 0.501 | 100 | − 2.681 | 1.862 | |
| 46 m/z | 49.029 | − 0.646 | 3/3 | 1.299 | 77.865 | − 3.499 | 2.359 | |
| 98 m/z | 106.194 | − 0.578 | 3/3 | 0.821 | 81.893 | − 2.996 | 2.244 | |
| 163 m/z | 168.192 | 1.250 | 0/3 | − 0.868 | 100 | − 2.887 | 1.891 | |
| 43 m/z II | 46.069 | − 0.001 | 1/1 | 0.782 | 98.262 | − 2.611 | 2.028 | |
| Remdesivir | 602.585 | 2.312 | 13/13 | − 3.56 | 43.813 | − 5.006 | 2.213 | |
| 57 m/z | 58.036 | − 0.110 | 2/1 | 1.199 | 95.919 | − 2.705 | 2.030 | |
| 161 m/z | 166.208 | − 2.321 | 8/4 | − 1.112 | 56.409 | − 3.974 | 1.992 | |
| 160 m/z | 169.232 | − 1.675 | 4/5 | − 1.091 | 54.990 | − 4.000 | 2.029 | |
| 218 m/z | 223.236 | − 2.129 | 3/7 | − 1.957 | 63.682 | − 3.675 | 2.226 | |
| 56 m/z | 60.096 | 0.389 | 1/1 | 0.360 | 96.667 | − 2.537 | 1.984 | |
| 328 m/z | 329.333 | 3.123 | 2/4 | − 3.279 | 89.124 | − 2.817 | 2.511 | |
| 85 m/z | 86.178 | 2.442 | 0/0 | − 2.547 | 95.502 | − 2.113 | 1.944 | |
| 44 m/z | 47.057 | − 1.105 | 2/2 | 1.465 | 84.154 | − 2.696 | 1.878 | |
| 90 m/z | 93.066 | 0.097 | 2/2 | 0.311 | 93.366 | − 2.994 | 2.169 | |
| 201 m/z | 203.205 | − 0.089 | 2/6 | − 2.983 | 76.079 | − 3.111 | 2.222 | |
| 59 m/z | 62.068 | − 1.029 | 2/2 | 1.664 | 86.716 | − 2.932 | 1.857 | |
| 30 m/z | 30.026 | − 0.185 | 1/0 | 0.722 | 100 | − 2.393 | 2.040 | |
| 219 m/z | 219.221 | 2.151 | 1/3 | − 1.619 | 92.118 | − 2.947 | 3.026 | |
| 93 m/z | 98.145 | 1.520 | 1/0 | − 0.963 | 97.244 | − 2.739 | 2.040 | |
| Ribavirin | 166.208 | − 2.321 | 4/3 | − 1.112 | 56.409 | − 3.974 | 1.996 | |
| 59 m/z | 60.052 | − 0.882 | 2/1 | 1.156 | 95.474 | − 2.743 | 1.846 | |
| 83 m/z | 90.126 | − 1.297 | 3/3 | 0.140 | 80.546 | − 2.923 | 1.765 | |
| 31 m/z I | 32.042 | − 0.392 | 1/1 | 1.075 | 98.165 | − 2.566 | 2.029 | |
| 142 m/z | 144.130 | − 1.406 | 2/4 | 0.04 | 77.520 | − 3.167 | 1.914 | |
| 27 m/z | 27.026 | 0.140 | 1/0 | 0.162 | 100 | − 2.375 | 2.351 | |
| 44 m/z | 47.057 | − 1.105 | 2/2 | 1.465 | 84.154 | − 2.696 | 1.878 | |
| 60 m/z | 62.068 | − 1.029 | 2/2 | 1.310 | 86.376 | − 2.916 | 1.570 | |
| 111 m/z | 112.092 | − 1.096 | 2/3 | − 1.065 | 73.849 | − 3.903 | 1.900 | |
| 133 m/z | 134.131 | − 1.553 | 3/4 | − 0.108 | 73.940 | − 3.855 | 1.215 | |
| 31 m/z II | 32.042 | − 0.392 | 1/1 | 1.075 | 98.165 | − 2.566 | 2.029 | |
| 102 m/z | 104.105 | − 1.071 | 2/3 | 1.030 | 81.777 | − 3.420 | 1.378 | |
| Chloroquine | 319.880 | 4.811 | 3/1 | − 4.014 | 89.244 | − 2.963 | 2.982 | |
| 29 m/z | 30.070 | 1.026 | 0/0 | − 0.623 | 100 | − 2.344 | 2.182 | |
| 56 m/z | 59.112 | 0.226 | 1/1 | 0.452 | 100 | − 2.673 | 2.198 | |
| 57 m/z | 57.096 | 0.707 | 1/0 | − 0.156 | 100 | − 2.505 | 2.277 | |
| 177 m/z | 182.654 | 2.155 | 2/2 | − 1.710 | 88.700 | − 2.218 | 3.261 | |
| 86 m/z | 87.166 | 0.958 | 1/0 | − 0.303 | 100 | − 2.807 | 2.173 | |
| 233 m/z | 236.746 | 3.875 | 2/1 | − 2.174 | 88.330 | − 2.294 | 3.332 | |
| 28 m/z | 30.070 | 1.026 | 0/0 | − 0.623 | 100 | − 2.344 | 2.182 | |
| 205 m/z | 206.676 | 3.320 | 2/1 | − 3.236 | 91.953 | − 2.331 | 2.516 | |
| Hydroxychloroquine | 321.852 | 3.740 | 4/2 | − 3.347 | 89.139 | − 2.194 | 2.770 | |
| 142 m/z | 148.209 | 1.502 | 2/2 | − 1.437 | 90.287 | − 2.172 | 3.233 | |
| 144 m/z | 145.246 | 1.488 | 2/1 | − 0.765 | 92.423 | − 2.900 | 2.123 | |
| 113 m/z | 115.220 | 1.786 | 1/1 | − 1.367 | 93.158 | − 2.545 | 2.334 | |
| 31 m/z | 32.042 | − 0.391 | 1/1 | 1.075 | 98.165 | − 2.566 | 2.029 |
ADMET parameters: MW molecular weight, D.H number of Hbonds donors, A.H. number of Hbonds acceptors, logP partition coefficient, logS predicted aqueous solubility (mol L−1), CNS predicted central nervous system, Tox Oral Rat Acute Toxicity (mol Kg−1).